Maximizing retention with high risk participants in a clinical trial

American Journal of Health Promotion

Volumn 28, Issue 4, 2014, Pages 268-274

  Kim, Romina ^a   Hickman, Norval ^a   Gali, Kathleen ^a   Orozco, Nicholas ^a   Prochaska, Judith J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

California; Clinical Trial; Ethnically racially diverse population; Health focus: smoking control; Outcome measure: behavioral productivity; Outreach; Prevention Research. Manuscript format: research; Research purpose: intervention testing program evaluation; Retention; San Francisco; Setting: clinic health care and local community; Strategy: skill building behavior change; Study design: randomized trial; Target population age: adults; Target population circumstances: all education and income levels; Vulnerable Populations

Indexed keywords

ADULT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERAL HOSPITAL; HUMAN; MALE; MENTAL DISEASE; MIDDLE AGED; PATIENT DROPOUTS; POVERTY; PSYCHOLOGY; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER; UNITED STATES;

ADULT; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, GENERAL; HOSPITALS, PUBLIC; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT DROPOUTS; POVERTY; RISK FACTORS; SAN FRANCISCO; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84897763270     PISSN: 08901171     EISSN: None     Source Type: Journal    
DOI: 10.4278/ajhp.120720-QUAN-355     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. PRS efficacy criteria for bestevidence (Tier I) risk reduction (RR) individual-level and group-level interventions (ILIs/GLIs). 2011. Available at: http://www.cdc.gov/hiv/topics/ research/prs/efficacy-best-evidence-ILIs-GLIs.htm. Accessed November 28, 2012.
2. El-Khorazaty MN, Johnson AA, Kiely M. Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancy. BMC Public Health. 2007;7:233.
3. DeCoux Hampton M, White MC. Eligibility, recruitment, and retention of African Americans with severe mental illness in community research. Community Ment Health J. 2009;45:137-143.
4. Napoles AM, Chadiha LA. Advancing the science of recruitment and retention of ethnically diverse populations. Gerontologist. 2011;51:S142-S146.
5. National Institutes of Health, Office of Research on Women's Health, Office of Extramural Research, et al. Outreach notebook for the inclusion, recruitment and retention of women and minority subjects in clinical research. 2002. Available at: http://orwh.od.nih.gov/pubs/outreach.pdf. Accessed November 10, 2011.
6. Zook PM, Jordan C, Adams B, et al. Retention strategies and predictors of attrition in an urban pediatric asthma study. Clin Trials J. 2010;7:400-410.
7. Nicholson LM, Schwirian PM, Klein EG, et al. Recruitment and retention strategies in longitudinal clinical studies with lowincome populations. Contemp Clin Trials. 2011;32:353-362.
8. Dilworth-Anderson P. Introduction to the science of recruitment and retention among ethnically diverse populations. Gerontologist. 2011;51 (S1):S1-S4.
9. Reidy MC, Orpinas P, Davis M. Successful recruitment and retention of Latino study participants. Health Promot Pract. 2012; 13 (6):779-87.
10. Prochaska JJ. Smoking and mental illness: breaking the link. N Engl J Med. 2011;365: 196-198.
11. Patten CA, Martin JE, Filter KJ, Wolter TD. Utility and accuracy of collateral reports of smoking status among 256 abstinent alcoholic smokers treated for smoking cessation. Addict Behav. 2002;27:687-696.
12. San Francisco General Hospital & Trauma Center. Annual report FY 2010-2011. Available at: http://www.sfdph.org/dph/files/SFGHdocs/ AnnlRpt20102011.pdf. Accessed August 2, 2012.
13. Hickman NJ, Prochaska JJ, Dunn LB. Screening for understanding of research in the inpatient psychiatry setting. J Empir Res Hum Res Ethics. 2011;6:65-72.
14. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
15. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51:390-395.
16. McLellan AT, Alterman AI, Cacciola J, et al. A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis. 1992;180: 101-110.
17. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Screening Test (AUDIT). WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction. 1993;88:791-804.
18. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat. 2007;32:189-198.
19. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1997;1:385-401.
20. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
21. Ware C. Information Visualization: Perception for Design. 2nd ed. San Francisco, Calif: Elsevier; 2004.
22. Menendez E, White MC, Tulsky JP. Locating study subjects: predictors and successful search strategies with inmates related from a U.S. county jail. Control Clin Trials. 2001;33:238-247.
23. Bolanos F, Herbeck D, Christou D, et al. Using Facebook to maximize follow-up response rates in a longitudinal study of adults who use methamphetamine. Subst Abuse. 2012;6:1-11.
24. Leathem CS, Cupples ME, Byrne MC, et al. Identifying strategies to maximise recruitment and retention of practices and patients in a multicenter randomised controlled trial of an intervention to optimise secondary prevention for coronary heart disease in primary care. BMC Med Res Methodol. 2009;9:40.